Study of A-319 in Patients With Relapsed or Refractory B-cell Lymphoma
Clinical trial NCT04056975 · UNKNOWN
Trial details
- NCT number
- NCT04056975
- Sponsor
- EVIVE Biotechnology
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-15
- Primary completion
- 2021-09-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.